Report cover image

Global Allogeneic Stem Cell Therapies Competitive Landscape Professional Research Report 2024

Publisher DIResearch
Published Jun 10, 2024
Length 170 Pages
SKU # DIR18897162

Description

Global Allogeneic Stem Cell Therapies Competitive Landscape Professional Research Report 2024



Research Summary

Allogeneic cell therapies refer to treatments that use cells from a donor other than the recipient. These cells can be derived from various sources, including bone marrow, umbilical cord blood, and peripheral blood. The goal of allogeneic cell therapies is to harness the properties of these cells to treat a range of diseases and conditions, such as cancer, autoimmune disorders, and genetic diseases. In many cases, these therapies involve modifying the donor cells to enhance their therapeutic potential or to reduce the risk of rejection by the recipient＇s immune system.

According to DIResearch's in-depth investigation and research, the global Allogeneic Stem Cell Therapies market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Allogeneic Stem Cell Therapies include Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Anterogen, MolMed S.p.A., Takeda (TiGenix) etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Allogeneic Stem Cell Therapies. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Allogeneic Stem Cell Therapies market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Allogeneic Stem Cell Therapies market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Allogeneic Stem Cell Therapies industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Allogeneic Stem Cell Therapies Include:

Escape Therapeutics, Inc.

Lonza Group Ltd.

Osiris Therapeutics (Smith & Nephew)

NuVasive

Chiesi Pharmaceuticals

JCR Pharmaceutical

Pharmicell

Anterogen

MolMed S.p.A.

Takeda (TiGenix)

Allogeneic Stem Cell Therapies Product Segment Include:

Adult Stem Cell Therapy

Human Embryonic Stem Cell Therapy

Induced Pluripotent Stem Cell Therapy

Others

Allogeneic Stem Cell Therapies Product Application Include:

Musculoskeletal Disorder

Wounds & Injuries

Cardiovascular Diseases

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Allogeneic Stem Cell Therapies Industry PESTEL Analysis

Chapter 3: Global Allogeneic Stem Cell Therapies Industry Porter’s Five Forces Analysis

Chapter 4: Global Allogeneic Stem Cell Therapies Major Regional Market Size and Forecast Analysis

Chapter 5: Global Allogeneic Stem Cell Therapies Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Allogeneic Stem Cell Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Allogeneic Stem Cell Therapies Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

170 Pages
1 Allogeneic Stem Cell Therapies Market Overview
1.1 Product Definition and Statistical Scope
1.2 Allogeneic Stem Cell Therapies Product by Type
1.2.1 Global Allogeneic Stem Cell Therapies Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Adult Stem Cell Therapy
1.2.3 Human Embryonic Stem Cell Therapy
1.2.4 Induced Pluripotent Stem Cell Therapy
1.2.5 Others
1.3 Allogeneic Stem Cell Therapies Product by Application
1.3.1 Global Allogeneic Stem Cell Therapies Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Musculoskeletal Disorder
1.3.3 Wounds & Injuries
1.3.4 Cardiovascular Diseases
1.3.5 Others
1.4 Global Allogeneic Stem Cell Therapies Market Revenue Analysis (2019-2030)
1.5 Allogeneic Stem Cell Therapies Market Development Status and Trends
1.5.1 Allogeneic Stem Cell Therapies Industry Development Status Analysis
1.5.2 Allogeneic Stem Cell Therapies Industry Development Trends Analysis
2 Allogeneic Stem Cell Therapies Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Allogeneic Stem Cell Therapies Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Allogeneic Stem Cell Therapies Market Analysis by Regions
4.1 Allogeneic Stem Cell Therapies Overall Market: 2023 VS 2024 VS 2030
4.2 Global Allogeneic Stem Cell Therapies Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Allogeneic Stem Cell Therapies Revenue and Market Share by Region (2019-2024)
4.2.2 Global Allogeneic Stem Cell Therapies Revenue Forecast by Region (2025-2030)
5 Global Allogeneic Stem Cell Therapies Market Size by Type and Application
5.1 Global Allogeneic Stem Cell Therapies Market Size by Type
5.2 Global Allogeneic Stem Cell Therapies Market Size by Application
6 North America
6.1 North America Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Allogeneic Stem Cell Therapies Market Size by Type
6.4 North America Allogeneic Stem Cell Therapies Market Size by Application
6.5 North America Allogeneic Stem Cell Therapies Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Allogeneic Stem Cell Therapies Market Size by Type
7.4 Europe Allogeneic Stem Cell Therapies Market Size by Application
7.5 Europe Allogeneic Stem Cell Therapies Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Allogeneic Stem Cell Therapies Market Size by Type
8.4 China Allogeneic Stem Cell Therapies Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Allogeneic Stem Cell Therapies Market Size by Type
9.4 APAC (excl. China) Allogeneic Stem Cell Therapies Market Size by Application
9.5 APAC (excl. China) Allogeneic Stem Cell Therapies Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Allogeneic Stem Cell Therapies Market Size by Type
10.4 Latin America Allogeneic Stem Cell Therapies Market Size by Application
10.5 Latin America Allogeneic Stem Cell Therapies Market Size by Country
10.5.1 Mecixo
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Allogeneic Stem Cell Therapies Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Allogeneic Stem Cell Therapies Market Size by Type
11.4 Middle East & Africa Allogeneic Stem Cell Therapies Market Size by Application
11.5 Middle East & Africa Allogeneic Stem Cell Therapies Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Market Competition by Manufacturers
12.1 Global Allogeneic Stem Cell Therapies Market Revenue by Key Manufacturers (2020-2024)
12.2 Allogeneic Stem Cell Therapies Competitive Landscape Analysis and Market Dynamic
12.2.1 Allogeneic Stem Cell Therapies Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Escape Therapeutics, Inc.
13.1.1 Escape Therapeutics, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapies Product Portfolio
13.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.2 Lonza Group Ltd.
13.2.1 Lonza Group Ltd. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Lonza Group Ltd. Allogeneic Stem Cell Therapies Product Portfolio
13.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.3 Osiris Therapeutics (Smith & Nephew)
13.3.1 Osiris Therapeutics (Smith & Nephew) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapies Product Portfolio
13.3.3 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.4 NuVasive
13.4.1 NuVasive Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 NuVasive Allogeneic Stem Cell Therapies Product Portfolio
13.4.3 NuVasive Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.5 Chiesi Pharmaceuticals
13.5.1 Chiesi Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapies Product Portfolio
13.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.6 JCR Pharmaceutical
13.6.1 JCR Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 JCR Pharmaceutical Allogeneic Stem Cell Therapies Product Portfolio
13.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.7 Pharmicell
13.7.1 Pharmicell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Pharmicell Allogeneic Stem Cell Therapies Product Portfolio
13.7.3 Pharmicell Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.8 Anterogen
13.8.1 Anterogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Anterogen Allogeneic Stem Cell Therapies Product Portfolio
13.8.3 Anterogen Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.9 MolMed S.p.A.
13.9.1 MolMed S.p.A. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 MolMed S.p.A. Allogeneic Stem Cell Therapies Product Portfolio
13.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.10 Takeda (TiGenix)
13.10.1 Takeda (TiGenix) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Takeda (TiGenix) Allogeneic Stem Cell Therapies Product Portfolio
13.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Allogeneic Stem Cell Therapies Industry Chain Analysis
14.2 Allogeneic Stem Cell Therapies Industry Raw Material and Suppliers Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Allogeneic Stem Cell Therapies Typical Downstream Customers
14.4 Allogeneic Stem Cell Therapies Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us